HB 1672-FN (2018): prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1672-FN (2018): prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies.” Granite Record, https://graniterecord.org/bill/2018/hb1672. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1672-FN (2018): prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2018/hb1672
- Chicago
- Granite Record. “HB 1672-FN (2018): prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2018/hb1672.
- BibTeX
@misc{bill-2018-hb1672, title = {HB 1672-FN (2018): prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2018/hb1672}, note = {Accessed 24 Oct. 2026} }
HB 1672-FN (2018)
prohibiting release of certain information relative to users of therapeutic cannabis to federal agencies.
- Status: Died on the table
- Term: 2017-2018
- House committee: Judiciary
- Senate committee: Judiciary
- Subject: Public and Mental Health
The Story
It was introduced on January 3, 2018 and referred to the House Judiciary committee. The committee held a public hearing on January 25, 2018. The committee met in executive session on February 21, 2018 to vote on its recommendation. The committee voted 13–5 to recommend that the House pass it, and the report was placed on the regular calendar. On March 6, 2018 the House adopted “Suspend House Rule 65 (Reps. Hinch, Shurtleff)” on a voice vote. On March 15, 2018 the House voted to pass it on a roll call 313–18. It crossed to the Senate on March 21, 2018 and was referred to the Senate Judiciary committee. The committee held a public hearing on March 27, 2018. The committee recommended that the Senate pass it. On April 19, 2018 the Senate voted to lay it on the table on a voice vote, on a motion by Sen. Bradley.
Sponsors
- Rep. Caleb Dyer (L - Hills 37) (prime sponsor)
- Rep. Joseph Stallcop (D - Ches 4)
- Rep. Dan Hynes (I - Hills 21)
- Rep. Timothy Josephson (D - Graf 11)
- Rep. James McConnell (R - Ches 12)
Hearings and Sessions
- January 25, 2018, 11:00 AM: public hearing, House Judiciary, LOB 208
- February 21, 2018: executive session, House Judiciary, LOB 208
- March 27, 2018, 9:30 AM: hearing, Senate Judiciary, SH 100
Votes
- March 6, 2018, House: Suspend House Rule 65 (Reps. Hinch, Shurtleff) — voice vote, passed
- March 15, 2018, House: Ought to Pass — yeas 313, nays 18, passed
- April 19, 2018, Senate: Laid on Table — voice vote, passed
The Docket
- January 3, 2018: Introduced 01/03/2018 and referred to Judiciary
- January 25, 2018: Public Hearing: 01/25/2018 11:00 AM LOB 208
- February 21, 2018: Executive Session: 02/21/2018 LOB 208
- March 6, 2018: Committee Report: Ought to Pass for 03/06/2018 (Vote 13-5; RC)
- March 6, 2018: Suspend House Rule 65 (Reps. Hinch, Shurtleff): MA VV by necessary two-thirds vote 03/06/2018
- March 7, 2018: Special Order to 3/15/2018 Without Objection
- March 15, 2018: Ought to Pass : MA RC 313-18 03/15/2018
- March 21, 2018: Introduced 03/21/2018 and Referred to Judiciary
- March 27, 2018: Hearing: 03/27/2018, Room 100, SH, 09:30 am
- April 19, 2018: Committee Report: Ought to Pass, 04/19/2018
- April 19, 2018: Sen. Bradley Moved Laid on Table, MA, VV; 04/19/2018
- April 19, 2018: Pending Motion Ought to Pass; 04/19/2018